Skip to content
Catalyst

Pleurotus eryngiiFinding

Pleurotus eryngii decreases interleukin‑6 concentration

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“IL-6 and oxLDL decreased in the intervention group after 3 months and remained unchanged in the control group, with the mean changes being significantly different between the two groups.”
Quoted verbatim from A Randomized Controlled Trial on Pleurotus eryngii Mushrooms with Antioxidant Compounds and Vitamin D2 in Managing Metabolic Disorders.
This finding among the 87 findings on its endpoint

Pleurotus eryngii

Interleukin-6 concentration

lowers

Who
100 metabolically unhealthy adults (aged 18-76) with metabolic disorders in Athens, randomised to the mushroom snack plus standard nutritional counseling or to counseling alone; the 3-month change in each arm was compared
Dose studied
snack consumed daily for 3 months; 6 g per sachet (sachets per day not stated)

Moderate evidencePMID 36358485 · 2022

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M729BRJK24ZWYCZE9T89GZQF